BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 15959782)

  • 1. The role of mucosal T lymphocytes in regulating intestinal inflammation.
    Uhlig HH; Powrie F
    Springer Semin Immunopathol; 2005 Sep; 27(2):167-80. PubMed ID: 15959782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of intestinal homeostasis by regulatory T cells and dendritic cells.
    Coombes JL; Maloy KJ
    Semin Immunol; 2007 Apr; 19(2):116-26. PubMed ID: 17320411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RANK-RANKL signaling pathway is critically involved in the function of CD4+CD25+ regulatory T cells in chronic colitis.
    Totsuka T; Kanai T; Nemoto Y; Tomita T; Okamoto R; Tsuchiya K; Nakamura T; Sakamoto N; Akiba H; Okumura K; Yagita H; Watanabe M
    J Immunol; 2009 May; 182(10):6079-87. PubMed ID: 19414759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory lymphocytes and intestinal inflammation.
    Izcue A; Coombes JL; Powrie F
    Annu Rev Immunol; 2009; 27():313-38. PubMed ID: 19302043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal IFN-γ-producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL-10 in the inflamed guts of patients with inflammatory bowel disease.
    Alfen JS; Larghi P; Facciotti F; Gagliani N; Bosotti R; Paroni M; Maglie S; Gruarin P; Vasco CM; Ranzani V; Frusteri C; Iseppon A; Moro M; Crosti MC; Gatti S; Pagani M; Caprioli F; Abrignani S; Flavell RA; Geginat J
    J Allergy Clin Immunol; 2018 Nov; 142(5):1537-1547.e8. PubMed ID: 29369775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4(+) T-cell subsets in intestinal inflammation.
    Shale M; Schiering C; Powrie F
    Immunol Rev; 2013 Mar; 252(1):164-82. PubMed ID: 23405904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-7 promotes long-term in vitro survival of unique long-lived memory subset generated from mucosal effector memory CD4+ T cells in chronic colitis mice.
    Takahara M; Nemoto Y; Oshima S; Matsuzawa Y; Kanai T; Okamoto R; Tsuchiya K; Nakamura T; Yamamoto K; Watanabe M
    Immunol Lett; 2013; 156(1-2):82-93. PubMed ID: 24070768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional Specialisation of T Cell Subsets and Apoptosis in the Human Gut Mucosa: Differences Between Ileum and Colon in Healthy Intestine and Inflammatory Bowel Diseases.
    Carrasco A; Fernández-Bañares F; Pedrosa E; Salas A; Loras C; Rosinach M; Aceituno M; Andújar X; Forné M; Zabana Y; Esteve M
    J Crohns Colitis; 2016 Sep; 10(9):1042-54. PubMed ID: 26995182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of induction of suppressor T cells by intestinal epithelial cells from patients with inflammatory bowel disease.
    Mayer L; Eisenhardt D
    J Clin Invest; 1990 Oct; 86(4):1255-60. PubMed ID: 2145321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal models of intestinal inflammation: ineffective communication between coalition members.
    Lorenz RG; McCracken VJ; Elson CO
    Springer Semin Immunopathol; 2005 Sep; 27(2):233-47. PubMed ID: 16028027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th9 cells in inflammatory bowel diseases.
    Weigmann B; Neurath MF
    Semin Immunopathol; 2017 Jan; 39(1):89-95. PubMed ID: 27837255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential role for regulatory T-cells in the amelioration of DSS induced colitis by dietary non-digestible polysaccharides.
    Hartog A; Belle FN; Bastiaans J; de Graaff P; Garssen J; Harthoorn LF; Vos AP
    J Nutr Biochem; 2015 Mar; 26(3):227-33. PubMed ID: 25498760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
    Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
    Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ Foxp3+ regulatory T cells suppress γδ T-cell effector functions in a model of T-cell-induced mucosal inflammation.
    Yurchenko E; Levings MK; Piccirillo CA
    Eur J Immunol; 2011 Dec; 41(12):3455-66. PubMed ID: 21956668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical model of the roles of T cells in inflammatory bowel disease.
    Lo WC; Arsenescu RI; Friedman A
    Bull Math Biol; 2013 Sep; 75(9):1417-33. PubMed ID: 23760658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosenescent colitogenic CD4(+) T cells convert to regulatory cells and suppress colitis.
    Totsuka T; Kanai T; Nemoto Y; Tomita T; Tsuchiya K; Sakamoto N; Okamoto R; Watanabe M
    Eur J Immunol; 2008 May; 38(5):1275-86. PubMed ID: 18412161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The cytokines in inflammatory bowel disease].
    Polińska B; Matowicka-Karna J; Kemona H
    Postepy Hig Med Dosw (Online); 2009 Aug; 63():389-94. PubMed ID: 19724079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune regulation in the intestine: a balancing act between effector and regulatory T cell responses.
    Powrie F
    Ann N Y Acad Sci; 2004 Dec; 1029():132-41. PubMed ID: 15681752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin induces the tolerogenic dendritic cell that promotes differentiation of intestine-protective regulatory T cells.
    Cong Y; Wang L; Konrad A; Schoeb T; Elson CO
    Eur J Immunol; 2009 Nov; 39(11):3134-46. PubMed ID: 19839007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell-mediated immunoregulation in the gastrointestinal tract.
    Saurer L; Mueller C
    Allergy; 2009 Apr; 64(4):505-19. PubMed ID: 19210347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.